Xie Q - Search Results

1

Incidences and Determinants of Functional Cure During Entecavir or Tenofovir Disoproxil Fumarate for Chronic Hepatitis B.

Hsu YC, Yeh ML, Wong GL, Chen CH, Peng CY, Buti M, Enomoto M, Xie Q, Trinh H, Preda C, Liu L, Cheung KS, Yeo YH, Hoang J, Huang CF, Riveiro-Barciela M, Kozuka R, Istratescu D, Tsai PC, Accarino EV, Lee DH, Wu JL, Huang JF, Dai CY, Cheung R, Chuang WL, Yuen MF, Wong VW, Yu ML, Nguyen MH. Hsu YC, et al. Among authors: xie q. J Infect Dis. 2021 Dec 1;224(11):1890-1899. doi: 10.1093/infdis/jiab241. J Infect Dis. 2021. PMID: 33999179 Clinical Trial.

2

On-treatment serum HBsAg level is predictive of sustained off-treatment virologic response to telbivudine in HBeAg-positive chronic hepatitis B patients.

Cai W, Xie Q, An B, Wang H, Zhou X, Zhao G, Guo Q, Gu R, Bao S. Cai W, et al. Among authors: xie q. J Clin Virol. 2010 May;48(1):22-6. doi: 10.1016/j.jcv.2010.02.014. Epub 2010 Mar 15. J Clin Virol. 2010. PMID: 20233672

3

Viral sequence evolution in Chinese genotype 1b chronic hepatitis C patients experiencing unsuccessful interferon treatment.

Xiang X, Lu J, Dong Z, Zhou H, Tao W, Guo Q, Zhou X, Bao S, Xie Q, Zhong J. Xiang X, et al. Among authors: xie q. Infect Genet Evol. 2011 Mar;11(2):382-90. doi: 10.1016/j.meegid.2010.11.011. Epub 2010 Dec 13. Infect Genet Evol. 2011. PMID: 21147266

4

Distribution of hepatitis C virus genotypes in Chinese patients with chronic hepatitis C: correlation with patients' characteristics and clinical parameters.

Dong ZX, Zhou HJ, Wang JH, Xiang XG, Zhuang Y, Guo SM, Gui HL, Zhao GD, Tang WL, Wang H, Xie Q. Dong ZX, et al. Among authors: xie q. J Dig Dis. 2012 Nov;13(11):564-70. doi: 10.1111/j.1751-2980.2012.00636.x. J Dig Dis. 2012. PMID: 23107443

5

Response-guided peginterferon therapy in hepatitis B e antigen-positive chronic hepatitis B using serum hepatitis B surface antigen levels.

Sonneveld MJ, Hansen BE, Piratvisuth T, Jia JD, Zeuzem S, Gane E, Liaw YF, Xie Q, Heathcote EJ, Chan HL, Janssen HL. Sonneveld MJ, et al. Among authors: xie q. Hepatology. 2013 Sep;58(3):872-80. doi: 10.1002/hep.26436. Epub 2013 Jul 29. Hepatology. 2013. PMID: 23553752 Clinical Trial.

6

[Analysis of a randomized, double-blind, double-dummy, controlled, multicenter study confirmed the similar therapeutic efficacies of entecavir maleate and entecavir for treatment of HBeAg-positive chronic hepatitis B].

Xu JH, Yu YY, Si CW, Zeng Z, Li J, Mao Q, Zhang DZ, Tang H, Sheng JF, Chen XY, Ning Q, Shi GF, Xie Q, Zhang XQ, Dai J, Xu ZN. Xu JH, et al. Among authors: xie q. Zhonghua Gan Zang Bing Za Zhi. 2013 Dec;21(12):881-5. doi: 10.3760/cma.j.issn.1007-3418.2013.12.001. Zhonghua Gan Zang Bing Za Zhi. 2013. PMID: 24636286 Clinical Trial. Chinese.

7

Long-term lamivudine treatment achieves regression of advanced liver fibrosis/cirrhosis in patients with chronic hepatitis B.

Xu B, Lin L, Xu G, Zhuang Y, Guo Q, Liu Y, Wang H, Zhou X, Wu S, Bao S, Cai W, Xie Q. Xu B, et al. Among authors: xie q. J Gastroenterol Hepatol. 2015 Feb;30(2):372-8. doi: 10.1111/jgh.12718. J Gastroenterol Hepatol. 2015. PMID: 25167956

8

A randomized, open-label clinical study of combined pegylated interferon Alfa-2a (40KD) and entecavir treatment for hepatitis B "e" antigen-positive chronic hepatitis B.

Xie Q, Zhou H, Bai X, Wu S, Chen JJ, Sheng J, Xie Y, Chen C, Chan HL, Zhao M. Xie Q, et al. Among authors: xie y. Clin Infect Dis. 2014 Dec 15;59(12):1714-23. doi: 10.1093/cid/ciu702. Epub 2014 Sep 4. Clin Infect Dis. 2014. PMID: 25190434 Clinical Trial.

9

IL28B genetic variations are associated with treatment response of patients with chronic hepatitis C in a Chinese Han population.

Dong ZX, Zhou HJ, Xiang XG, Guo SM, Zhuang Y, Zhao GD, Xie Q. Dong ZX, et al. Among authors: xie q. J Dig Dis. 2015 Feb;16(2):90-7. doi: 10.1111/1751-2980.12202. J Dig Dis. 2015. PMID: 25312023

10

Adding pegylated interferon to entecavir for hepatitis B e antigen-positive chronic hepatitis B: A multicenter randomized trial (ARES study).

Brouwer WP, Xie Q, Sonneveld MJ, Zhang N, Zhang Q, Tabak F, Streinu-Cercel A, Wang JY, Idilman R, Reesink HW, Diculescu M, Simon K, Voiculescu M, Akdogan M, Mazur W, Reijnders JG, Verhey E, Hansen BE, Janssen HL; ARES Study Group. Brouwer WP, et al. Among authors: xie q. Hepatology. 2015 May;61(5):1512-22. doi: 10.1002/hep.27586. Epub 2015 Feb 27. Hepatology. 2015. PMID: 25348661 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

6,531 results

Search Page